February 20, 2026—The American College of Cardiology (ACC)/American Heart Association (AHA) Joint Committee on Clinical Practice Guidelines and

It is without question an exciting time in the field of pulmonary embolism (PE), a serious and often life-threatening condition that has long been

Industry reps provide critical knowledge, training, and patient-focused resources that help enhance patient care.

Strategies for getting started, staying engaged, and shaping the future of your specialty and community.

Insights on how to refine your interests, strengthen your expertise, and step confidently onto the podium.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

January 15, 2026—Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under wh

January 14, 2026—Amplifi Vascular, Inc., a developer of solutions for hemodialysis vascular access, announced it has been granted Breakthrough D

January 8, 2026—The American College of Cardiology (ACC) and American Heart Association (AHA) have issued the “2026 ACC/AHA Clinical Perfo

January 5, 2026—Ceribell, Inc. announced that the FDA has granted Breakthrough Device designation for its large vessel occlusion (LVO) stroke de

December 19, 2025—Gore & Associates G.K. in Minato-ku, Tokyo, Japan, announced the first clinical use in Japan of the Gore Excluder thoracoa

Understanding the hazards of radiation and the importance of physical health in the endovascular suite and cath lab, and what seasoned interventionalists wish they had known and done sooner.

December 15, 2025—Gore & Associates announced the first implantation of its investigational Gore Ascending Stent Graft in the ARISE III tria

December 10, 2025—Biocoat, Inc. announced the formation of Surmodics Services & Technologies, a newly named division of Surmodics, Inc. that

On behalf of the Society for Vascular Surgery (SVS), Ali AbuRahma, MD, Past President of SVS; Marc Schermerhorn, MD, Past Chair, SVS Document Oversigh

December 3, 2025—Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and effect

December 3, 2025— Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation exp

Insights from PERT/DVT, limb salvage, and aortic team members on effective networking that lasts longer than the launch meeting.

November 24, 2025—Humacyte, Inc. announced that multiple presentations on the company’s acellular tissue-engineered vessel (ATEV) were del

Experts share advice for junior colleagues before their first case, including basic keys to success and pitfall avoidance, what to watch for when observing a case, and questions to ask and when to ask...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

November 19, 2025—Vexev and U.S. Renal Care announced the results of the CANSCAN feasibility trial, which provided evidence that Vexev’s V

November 18, 2025—Vesalio announced two FDA 510(k) clearances for its aspiration devices for peripheral and neurovascular applications, advancin

November 18, 2025—RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial

November 12, 2025—ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. Accor

November 11, 2025—Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intr

November 7, 2025—Gore & Associates announced trial results evaluating the investigational Viabahn Fortegra venous stent for the treatment of

November 3, 2025—Merit Medical Systems, Inc. announced 24-month efficacy outcomes from the nonrandomized arteriovenous graft (AVG) cohort of the

November 4, 2025—Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States pivotal

November 4, 2025— BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE)

November 3, 2025—Endovascular Engineering, Inc. (E2) announced positive results from the pivotal cohort of the ENGULF investigational device exe

October 31, 2025—Egg Medical, Inc. announced the presentation of real-world studies demonstrating that the company’s EggNest Complete radi

October 29, 2025—The Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD) on renal de

October 28, 2025—Thrombolex, Inc. announced findings from a prespecified interim analysis from the first 50 patients in the postmarket RAPID-PE

Practical advice for finding the right mentor, navigating challenges, and maximizing mentorship success.

October 27, 2025—Penumbra, Inc. announced that the results of the STORM-PE randomized controlled trial showed that mechanical thrombectomy using

October 22, 2025—Nurea announced that its PraevAorta 2 software has received FDA 510(k) clearance for the United States market. According to

October 22, 2025—Techsomed Ltd., an Israel-based developer of medical artificial intelligence–powered software for image-guided therapy, a

October 13, 2025—Remedy Robotics announced it has entered into a strategic partnership with the Australian Stroke Alliance to expand access to e

October 9, 2025—Penumbra announced the commercial launch of the SwiftSet coil, a complex embolization coil engineered to provide adaptive vessel

October 8, 2025—Remedy Robotics, Inc., announced the first-in-human (FIH) procedures with its remotely operable endovascular robotic system, Rem

October 8, 2025—Medtronic announced full distribution in the United States of Contego Medical’s Neuroguard integrated embolic protection (

Experts share advice on career decision-making, skill development, and balancing passions.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

September 24, 2025—The Society for Vascular Surgery (SVS) announced the release of updated clinical guidelines for the management of intermitten

September 22, 2025—Techsomed, a developer of image-guided therapy software, announced FDA 510(k) clearance of an expanded indication for the com

September 24, 2025—Interventional Systems and Siemens Healthineers announced a comarketing agreement to promote robot-assisted percutaneous proc

September 18, 2025—Imperative Care, Inc. announced efficacy and safety results from the pivotal SYMPHONY-PE trial. The prospective, multicenter

September 17, 2025—Quantum Surgical announced it has obtained CE Mark approval for the expanded use of its Epione robotic platform in the treatm

September 9, 2025—The Society of Interventional Radiology (SIR) announced that a new practice guidance for the creation of percutaneous arteriov